Zeng, Qiuming https://orcid.org/0000-0002-2021-1484
Guo, Hui
Tang, Na
Renavikar, Pranav S.
Karandikar, Nitin J.
Lovett-Racke, Amy E.
Racke, Michael K.
Yan, Chengkai
Tang, Rong
Sinha, Sushmita
Ghosh, Krishnendu
Ryal, Jeremy P.
Ouyang, Song
Chen, Min
Amari, Foued
Vincenzo, Coppola
Pope, R. Marshall
Li, Yalan
Yang, Huan
Langdon, Wallace Y.
Zhang, Jian
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01 AI090901, R01 AI121196, R01 AI123253)
Natural Science Foundation of Hunan Province (2023JJ30868)
National Natural Science Foundation of China (81801203)
Article History
Received: 28 May 2024
Accepted: 17 January 2025
First Online: 19 February 2025
Change Date: 16 April 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12929-025-01136-8
Declarations
:
: All animal experimental protocols were approved by the Institutional Animal Care and Use Committees of The Ohio State University and the University of Iowa. The sample collection of MS patients (treatment-naïve and in remission) was approved by the Institutional Review Boards (IRBs) of the Ohio State University and the University of Iowa. The sample collection of MS patients (treatment-naïve and in relapse) was approved by the Medical Ethics Committee of Xiangya Hospital of Central South University (NO. 201904147–2).
: Not applicable.
: The authors declare that they have no competing interests.